From gene-specific to function-specific risk stratification in long QT syndrome Type 2: implications for clinical management
EP Europace · 2023
DOI: 10.1093/europace/euad035 ↗Kurz gefasst
Editorial in der Zeitschrift EP Europace, 2023. Verfasst von Lia Crotti. Beteiligte Einrichtung: Istituto Auxologico Italiano IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Via Pierlombardo 22, …. Hauptthemen laut MEDLINE: Long QT Syndrome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Istituto Auxologico Italiano IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Via Pierlombardo 22, 20135, Milan, Italy.
- Department of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900, Monza, Italy.
ORCID-Profile: Lia Crotti
Zitieren
APA
Crotti, L. (2023). From gene-specific to function-specific risk stratification in long QT syndrome Type 2: implications for clinical management. EP Europace. https://doi.org/10.1093/europace/euad035
Vancouver
Crotti L. From gene-specific to function-specific risk stratification in long QT syndrome Type 2: implications for clinical management. EP Europace. 2023. doi:10.1093/europace/euad035
BibTeX
@article{Crotti2023,
author = {Crotti, Lia},
title = {From gene-specific to function-specific risk stratification in long QT syndrome Type 2: implications for clinical management},
journal = {EP Europace},
year = {2023},
doi = {10.1093/europace/euad035}
}
EUVIMED